Julie Smith Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Julie Smith.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Julie Smith. Julie Smith is a EVP, Strategy and COO in Raptor Pharmaceutical Corp ($RPTP) and a President and CEO in Raptor Pharmaceutical Corp ($RPTP) and a Director in EXELIXIS, INC. ($EXEL) and a Director in Stoke Therapeutics, Inc. ($STOK) and a Director in Audentes Therapeutics, Inc. ($BOLD).

Address: C/O RAPTOR PHARMACEUTICAL CORP 9 COMMERCIAL BLVD, SUITE 200 NOVATO 94949 CA

Companies in which Julie Smith is an Insider

Audentes Therapeutics, Inc.

Trading Symbol: BOLD
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Julie Smith: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jan 15 2020
$BOLD Market Capitalization: $337.82M
$BOLD Previous Close: $15.83

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

EXELIXIS, INC.

Trading Symbol: EXEL
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Julie Smith: Director
Holdings: 16,301 shares
Current Value: $335,312
Latest Transaction: May 22 2020
$EXEL Market Capitalization: $6.19B
$EXEL Previous Close: $20.57

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

HORIZON PHARMACEUTICAL LLC

Trading Symbol: RPTP
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Julie Smith: President and CEO, EVP, Strategy and COO
Holdings: 64,179 shares
Latest Transaction: Oct 26 2016

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Stoke Therapeutics, Inc.

Trading Symbol: STOK
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Julie Smith: Director
Holdings: 0 shares
Latest Transaction: Jun 05 2020

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Latest Insider Trading Transactions of Julie Smith

Sentiment: All, BOLD, EXEL, RPTP, STOK

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Jun 05 2020	STOK	Stoke Therapeutics ...	Smith Julie	Director	Option Exercise	A	26.53	29,555	784,094	29,555
May 22 2020	EXEL	EXELIXIS, INC.	Smith Julie	Director	Grant	A	0.00	15,538	0	16,301	763 to 16.3 K (+2,036.44 %)
May 22 2020	EXEL	EXELIXIS, INC.	Smith Julie	Director	Grant	A	0.00	15,538	0	16,301	763 to 16.3 K (+2,036.44 %)
Jan 15 2020	BOLD	Audentes Therapeut ...	Smith Julie	Director	Option Exercise	D	24.74	16,200	400,788	0
Jan 15 2020	BOLD	Audentes Therapeut ...	Smith Julie	Director	Option Exercise	D	38.65	10,000	386,500	0
Jan 15 2020	BOLD	Audentes Therapeut ...	Smith Julie	Director	Option Exercise	D	26.15	9,000	235,350	0
Jan 15 2020	BOLD	Audentes Therapeut ...	Smith Julie	Director	Option Exercise	D	17.85	18,000	321,300	0

View all Julie Smith insider transactions.